Hereditary angioedema (hae) Trials in Ottawa, Canada
Conditions / Hereditary angioedema (hae) / Ottawa, Canada
Hereditary angioedema (hae) is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02741596 | Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE | COMPLETED | PHASE3 |
| NCT06842823 | A Study of Navenibart in Participants With Hereditary Angioedema | RECRUITING | PHASE3 |
| NCT06669754 | Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05819775 | CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema | COMPLETED | PHASE3 |
| NCT02586805 | Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE | COMPLETED | PHASE3 |
| NCT00456508 | Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE) | COMPLETED | PHASE3 |
| NCT07428499 | Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE) | RECRUITING | — |
| NCT00457015 | Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE) | COMPLETED | PHASE3 |
| NCT04583007 | Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults | NO_LONGER_AVAILABLE | — |
| NCT02584959 | Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema | COMPLETED | PHASE3 |